123 related articles for article (PubMed ID: 26311755)
1. From 'control to elimination': a strategic change to win the end game.
Hopkins AD
Int Health; 2015 Sep; 7(5):304-5. PubMed ID: 26311755
[TBL] [Abstract][Full Text] [Related]
2. Financial and Economic Costs of the Elimination and Eradication of Onchocerciasis (River Blindness) in Africa.
Kim YE; Sicuri E; Tediosi F
PLoS Negl Trop Dis; 2015; 9(9):e0004056. PubMed ID: 26360917
[TBL] [Abstract][Full Text] [Related]
3. Can ivermectin mass treatments eliminate onchocerciasis in Africa?
Winnen M; Plaisier AP; Alley ES; Nagelkerke NJ; van Oortmarssen G; Boatin BA; Habbema JD
Bull World Health Organ; 2002; 80(5):384-91. PubMed ID: 12077614
[TBL] [Abstract][Full Text] [Related]
4. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
Cupp EW; Sauerbrey M; Richards F
Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and control of onchocerciasis: the threshold biting rate of savannah onchocerciasis in Africa.
Duerr HP; Eichner M
Int J Parasitol; 2010 May; 40(6):641-50. PubMed ID: 19941867
[TBL] [Abstract][Full Text] [Related]
6. Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination.
Duerr HP; Raddatz G; Eichner M
Int J Parasitol; 2011 Apr; 41(5):581-9. PubMed ID: 21255577
[TBL] [Abstract][Full Text] [Related]
7. Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment.
Coffeng LE; Stolk WA; Hoerauf A; Habbema D; Bakker R; Hopkins AD; de Vlas SJ
PLoS One; 2014; 9(12):e115886. PubMed ID: 25545677
[TBL] [Abstract][Full Text] [Related]
8. Progress toward elimination of onchocerciasis in the Americas.
Sauerbrey M; Rakers LJ; Richards FO
Int Health; 2018 Mar; 10(suppl_1):i71-i78. PubMed ID: 29471334
[TBL] [Abstract][Full Text] [Related]
9. Reaching the london declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa.
Turner HC; Walker M; Churcher TS; Osei-Atweneboana MY; Biritwum NK; Hopkins A; Prichard RK; Basáñez MG
Clin Infect Dis; 2014 Oct; 59(7):923-32. PubMed ID: 24944228
[TBL] [Abstract][Full Text] [Related]
10. Onchocerciasis and lymphatic filariasis elimination in Africa: it's about time.
Evans DS; Unnasch TR; Richards FO
Lancet; 2015 May; 385(9983):2151-2. PubMed ID: 26068266
[No Abstract] [Full Text] [Related]
11. Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis.
Stolk WA; Walker M; Coffeng LE; Basáñez MG; de Vlas SJ
Parasit Vectors; 2015 Oct; 8():552. PubMed ID: 26489937
[TBL] [Abstract][Full Text] [Related]
12. The onchocerciasis chronicle: from the beginning to the end?
Crump A; Morel CM; Omura S
Trends Parasitol; 2012 Jul; 28(7):280-8. PubMed ID: 22633470
[TBL] [Abstract][Full Text] [Related]
13. Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning.
Cromwell EA; Osborne JCP; Unnasch TR; Basáñez MG; Gass KM; Barbre KA; Hill E; Johnson KB; Donkers KM; Shirude S; Schmidt CA; Adekanmbi V; Adetokunboh OO; Afarideh M; Ahmadpour E; Ahmed MB; Akalu TY; Al-Aly Z; Alanezi FM; Alanzi TM; Alipour V; Andrei CL; Ansari F; Ansha MG; Anvari D; Appiah SCY; Arabloo J; Arnold BF; Ausloos M; Ayanore MA; Baig AA; Banach M; Barac A; Bärnighausen TW; Bayati M; Bhattacharyya K; Bhutta ZA; Bibi S; Bijani A; Bohlouli S; Bohluli M; Brady OJ; Bragazzi NL; Butt ZA; Carvalho F; Chatterjee S; Chattu VK; Chattu SK; Cormier NM; Dahlawi SMA; Damiani G; Daoud F; Darwesh AM; Daryani A; Deribe K; Dharmaratne SD; Diaz D; Do HT; El Sayed Zaki M; El Tantawi M; Elemineh DA; Faraj A; Fasihi Harandi M; Fatahi Y; Feigin VL; Fernandes E; Foigt NA; Foroutan M; Franklin RC; Gubari MIM; Guido D; Guo Y; Haj-Mirzaian A; Hamagharib Abdullah K; Hamidi S; Herteliu C; Hidru HD; Higazi TB; Hossain N; Hosseinzadeh M; Househ M; Ilesanmi OS; Ilic MD; Ilic IM; Iqbal U; Irvani SSN; Jha RP; Joukar F; Jozwiak JJ; Kabir Z; Kalankesh LR; Kalhor R; Karami Matin B; Karimi SE; Kasaeian A; Kavetskyy T; Kayode GA; Kazemi Karyani A; Kelbore AG; Keramati M; Khalilov R; Khan EA; Khan MNN; Khatab K; Khater MM; Kianipour N; Kibret KT; Kim YJ; Kosen S; Krohn KJ; Kusuma D; La Vecchia C; Lansingh VC; Lee PH; LeGrand KE; Li S; Longbottom J; Magdy Abd El Razek H; Magdy Abd El Razek M; Maleki A; Mamun AA; Manafi A; Manafi N; Mansournia MA; Martins-Melo FR; Mazidi M; McAlinden C; Meharie BG; Mendoza W; Mengesha EW; Mengistu DT; Mereta ST; Mestrovic T; Miller TR; Miri M; Moghadaszadeh M; Mohammadian-Hafshejani A; Mohammadpourhodki R; Mohammed S; Mohammed S; Moradi M; Moradzadeh R; Moraga P; Mosser JF; Naderi M; Nagarajan AJ; Naik G; Negoi I; Nguyen CT; Nguyen HLT; Nguyen TH; Nikbakhsh R; Oancea B; Olagunju TO; Olagunju AT; Omar Bali A; Onwujekwe OE; Pana A; Pourjafar H; Rahim F; Rahman MHU; Rathi P; Rawaf S; Rawaf DL; Rawassizadeh R; Resnikoff S; Reta MA; Rezapour A; Rubagotti E; Rubino S; Sadeghi E; Saghafipour A; Sajadi SM; Samy AM; Sarmiento-Suárez R; Sawhney M; Schipp MF; Shaheen AA; Shaikh MA; Shamsizadeh M; Sharafi K; Sheikh A; Shetty BSK; Shin JI; Shivakumar KM; Simonetti B; Singh JA; Skiadaresi E; Soheili A; Soltani S; Spurlock EE; Sufiyan MB; Tabuchi T; Tapak L; Thompson RL; Thomson AJ; Traini E; Tran BX; Ullah I; Ullah S; Uneke CJ; Unnikrishnan B; Uthman OA; Vinkeles Melchers NVS; Violante FS; Wolde HF; Wonde TE; Yamada T; Yaya S; Yazdi-Feyzabadi V; Yip P; Yonemoto N; Yousof HSA; Yu C; Yu Y; Yusefzadeh H; Zaki L; Zaman SB; Zamanian M; Zhang ZJ; Zhang Y; Ziapour A; Hay SI; Pigott DM
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0008824. PubMed ID: 34319976
[TBL] [Abstract][Full Text] [Related]
14. The need for evidence-based strategies and tools for onchocerciasis elimination in Africa.
Dadzie Y; Amazigo UV; Boatin BA; Sékétéli A
Infect Dis Poverty; 2019 Jul; 8(1):62. PubMed ID: 31303174
[TBL] [Abstract][Full Text] [Related]
15. [Mass treatment of onchocerciasis in 1996].
Chovet M; Carlier C; Queguiner P; Mariko S
Med Trop (Mars); 1995; 55(4 Pt 2):425-8. PubMed ID: 10906977
[TBL] [Abstract][Full Text] [Related]
16. Diagnostics for onchocerciasis in the era of elimination.
Unnasch TR; Golden A; Cama V; Cantey PT
Int Health; 2018 Mar; 10(suppl_1):i20-i26. PubMed ID: 29471336
[TBL] [Abstract][Full Text] [Related]
17. Impact of combined large-scale ivermectin distribution and vector control on transmission of Onchocerca volvulus in the Niger basin, Guinea.
Guillet P; Sékétéli A; Alley ES; Agoua H; Boatin BA; Bissan Y; Akpoboua LK; Quillévéré D; Samba EM
Bull World Health Organ; 1995; 73(2):199-205. PubMed ID: 7743591
[TBL] [Abstract][Full Text] [Related]
18. Hypo-endemic onchocerciasis hotspots: defining areas of high risk through micro-mapping and environmental delineation.
Kelly-Hope LA; Unnasch TR; Stanton MC; Molyneux DH
Infect Dis Poverty; 2015; 4():36. PubMed ID: 26279835
[TBL] [Abstract][Full Text] [Related]
19. An Updated Economic Assessment of Moxidectin Treatment Strategies for Onchocerciasis Elimination.
Turner HC; Kura K; Roth B; Kuesel AC; Kinrade S; Basáñez MG
Clin Infect Dis; 2024 Apr; 78(Supplement_2):S138-S145. PubMed ID: 38662693
[TBL] [Abstract][Full Text] [Related]
20. Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa.
Kim YE; Remme JH; Steinmann P; Stolk WA; Roungou JB; Tediosi F
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003664. PubMed ID: 25860569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
